Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.50 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.49 |
| ▸ | GGT1 | P19440 | 1/20 | 0.49 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.47 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.47 |
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.45 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.44 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 7/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5023568 | 1.00 | FOLH1 (0.50) | FOLH1SLC6A5GGT1TLR2SIRT6 | |
| SCHEMBL29233125 | 0.92 | FOLH1 (0.44) | FOLH1SLC6A5GGT1TLR2SIRT6 | |
| SCHEMBL8751938 | 0.91 | SLC6A5 (0.55) | FOLH1SLC6A5GGT1TLR2SIRT6 | |
| SCHEMBL8751936 | 0.91 | SLC6A5 (0.55) | FOLH1SLC6A5GGT1TLR2SIRT6 | |
| SCHEMBL367557 | 0.90 | NOD1 (0.56) | FOLH1SLC6A5GGT1TLR2SIRT6 | |
| SCHEMBL367558 | 0.90 | NOD1 (0.56) | FOLH1SLC6A5GGT1TLR2SIRT6 | |
| SCHEMBL2050730 | 0.88 | NOD1 (0.58) | FOLH1SLC6A5GGT1TLR2SIRT6 | |
| SCHEMBL9791228 | 0.88 | NOD1 (0.58) | FOLH1SLC6A5GGT1TLR2SIRT6 | |
| SCHEMBL199411 | 0.88 | NOD1 (0.58) | FOLH1SLC6A5GGT1TLR2SIRT6 | |
| SCHEMBL31050906 | 0.88 | NOD1 (0.58) | FOLH1SLC6A5GGT1TLR2SIRT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119925300-A | IL 12 mRNA lipid nanoparticle and preparation method and application thereof | 杭州宜生医药科技发展有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| US-20240218014-A1 | SYNTHESIS OF A CYCLIC PEPTIDE | JANSSEN PHARMACEUTICA NV (BE) | 2024-07-04 | — | — | US | disclosed |
| US-20230129095-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | PROTAGONIST THERAPEUTICS, INC. (US) | 2023-04-27 | — | — | US | disclosed |
| US-20180346901-A1 | MEANS AND METHODS FOR PREPARING ENGINEERED PROTEINS BY GENETIC CODE EXPANSION IN INSECT CELLS | EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2018-12-06 | — | — | US | disclosed |
| EP-3384021-A1 | MEANS AND METHODS FOR PREPARING ENGINEERED PROTEINS BY GENETIC CODE EXPANSION IN INSECT CELLS | European Molecular Biology Laboratory (DE) | 2018-10-10 | — | — | EP | disclosed |
| WO-2017093254-A1 | MEANS AND METHODS FOR PREPARING ENGINEERED PROTEINS BY GENETIC CODE EXPANSION IN INSECT CELLS | EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2017-06-08 | — | — | WO | disclosed |
| US-20080188079-A1 | METAL-POLISHING COMPOSITION AND CHEMICAL MECHANICAL POLISHING METHOD BY USING THE SAME | FUJIFILM CORPORATION (JP) | 2008-08-07 | — | — | US | disclosed |
| US-20060263342-A1 | Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2006-11-23 | — | — | US | disclosed |
| US-5614510-A | AMMONIUM SALTS | PERSTORP AB (SE) | 1997-03-25 | — | — | US | disclosed |
| EP-0627922-A1 | A PHARMACEUTICAL COMPOSITION WITH IMPROVED BIOAVAILABILITY OF INOSITOL PHOSPHATE | PERSTORP AB (SE) | 1994-12-14 | — | — | EP | disclosed |
| WO-1993016705-A1 | A PHARMACEUTICAL COMPOSITION WITH IMPROVED BIOAVAILABILITY OF INOSITOL PHOSPHATE | PERSTORP AB (SE) | 1993-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240218014-A1 | SYNTHESIS OF A CYCLIC PEPTIDE | VIP, QPCT, PTMS | FOLH1 367/4885SLC6A5 3344/4885GGT1 1746/4885 |
| US-20180346901-A1 | MEANS AND METHODS FOR PREPARING ENGINEERED PROTEINS BY GENETIC CODE EXPANSION IN INSECT CELLS | IARS1, OSGEP, NSUN3 | FOLH1 364/4885SLC6A5 568/4885GGT1 623/4885 |
| US-20230129095-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | IL23R, IL1RN, VIP | FOLH1 640/4885SLC6A5 4668/4885GGT1 2088/4885 |
| US-20060263342-A1 | Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines | SPAG5, NASP, TMEM120A | FOLH1 243/4885SLC6A5 2960/4885GGT1 1756/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.